Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
 Comments
Keywords:   any keywords all keywords
Comments By:     Select Commentator
Posted Date:   From
  To    
Sort By:  
   
 
  * Comments posted before 22 May 2002 cannot be searched or sorted by posted date. Enter keywords and/or commentator and click this button to search only these comments.
Search Results: Comments By= Pimplikar, Sanjay W.; Sort By= Posted Date
1 to 30 of 31 results
Pimplikar S. on NEWS: Does ApoE4 Lower Brain Metabolism Independently of Aβ?, The finding that ApoE4 carriers display Aβ-independent pathomechanisms is not really... 19 Dec 2012. 

Pimplikar S. on NEWS: CTAD: New Data on Sola, Bapi, Spark Theragnostics Debate, The fact that there is a silver lining to the solanezumab trial is welcome news, even though it... 3 Dec 2012. 

Pimplikar S. on NEWS: Enter the New Alzheimer’s Gene: TREM2 Variant Triples Risk, With the increasing acceptance (1) that Alzheimer’s disease is a multifactorial disorder (2), it... 26 Nov 2012. 

Pimplikar S. on PAPER: Lauritzen I. et al., 2012, This study from the Checler group provides compelling evidence that 3xTg mice accumulate the C99... 17 Nov 2012. 

Pimplikar S. on NEWS: In Cells, Late- and Early-Onset Alzheimer’s Look Different, This study by Bali et al. provides compelling evidence that downregulation of the late-onset AD... 13 Sep 2012. 

Pimplikar S. on NEWS: Protective APP Mutation Found—Supports Amyloid Hypothesis, This study provides elegant genetic evidence that reducing the BACE processing of APP protects... 24 Jul 2012. 

Pimplikar S. on PAPER: Barten DM. et al., 2012, Coming hard on the heels of the work by Brunden and colleagues (Zhang et al., 2012), this study... 30 May 2012. 

Pimplikar S. on NEWS: NIH Director Announces $100M Prevention Trial of Genentech Antibody, The news that Genentech is providing major funding to support the upcoming prevention trial in... 23 May 2012. 

Pimplikar S. on NEWS: Biomarker Duo Signals Mental Decline, The conclusion that elevated CSF p-tau levels with reduced Aβ levels (Aβ+/p-tau+) are better... 15 May 2012. 

Pimplikar S. on NEWS: Antioxidants No Help for Alzheimer’s, Biomarker Trial Says, These conclusions are based on a four-month treatment, whereas most trials go on for 18 months,... 25 Mar 2012. 

Pimplikar S. on PAPER: Sperling RA. et al., 2011, Sperling et al. have put forward a now familiar argument (also proposed by others; 1-4) that... 7 Dec 2011. 

Pimplikar S. on NEWS: Aggressive Diabetes Treatment Slows Atrophy But Not Mental Slide, Alzforum should be commended for highlighting the ACCORD MIND study. At first glance, the... 12 Oct 2011. 

Pimplikar S. on PAPER: Cheng N. et al., 2011, In my view, the importance of this study lies in the finding that APP-induced neurodegeneration... 10 Oct 2011. 

Pimplikar S. on NEWS: Can Diet Influence Alzheimer’s Disease Biomarkers?, These are interesting studies, and the conclusions drawn by the authors, though based on a... 27 Jun 2011. 

Pimplikar S. on PAPER: Winton MJ. et al., 2011, It is a healthy sign that the paper by Winton et al. has initiated a debate over intraneuronal... 10 Jun 2011. 

Pimplikar S. on PAPER: Ioannidis JP. et al., 2011, The remarkable, if not entirely surprising, findings reported in this paper should be of... 9 Jun 2011. 

Pimplikar S. on PAPER: Swistowski A. et al., 2009, This study from Dale Bredesen’s group identifies TAZ and YAP as two potential downstream agents... 5 Jan 2010. 

Pimplikar S. on NEWS: APP Tail May Wag DNA Repair Pathway, This report from Tommaso Russo’s group represents a small but growing number of studies that are... 19 Mar 2009. 

Pimplikar S. on NEWS: Keystone: Death Receptor Ligand—New Role for APP, New Model for AD?, Reading this remarkable paper from the Tessier-Lavigne group feels like drinking water from a... 3 Mar 2009. 

Pimplikar S. on NEWS: Research Brief—Flurizan Fails Final Hurdle, Company Discontinues Drug, Flurizan Trial: Sic Transit Gloria Mundi The news that the Phase 3 trial of... 3 Jul 2008. 

Pimplikar S. on NEWS: San Diego: Oligomers Live Up to Bad Reputation, Part 1, Alzheimer Disease, Aβ Oligomers, and Shrek Gabrielle Strobel and Alzforum should be... 26 Nov 2007. 

Pimplikar S. on PAPER: Liu Q. et al., 2007, AICD Rules! Coming on the heels of the report that AICD represses transcription of... 10 Oct 2007. 

Pimplikar S. on LIVE DISCUSSION: APP Family: Clues to Function in Health and AD , Response to comment by Vincent Marchesi Dr. Marchesi correctly captures the essence... 9 Oct 2007. 

Pimplikar S. on NEWS: How Does Aβ Do Harm? New Clues on Insulin Signaling, Spines, Inflammation, The two papers that report the effects of “oligomeric” Aβ on insulin signaling pathways display... 18 Sep 2007. 

Pimplikar S. on PAPER: Ring S. et al., 2007, A Case of “Heads Win, Tails Don’t Lose” The progress in uncovering the function of... 3 Aug 2007. 

Pimplikar S. on PAPER: Zhang YW. et al., 2007, Whether or not AICD plays a transcriptional regulatory role has been much debated since the... 21 Jun 2007. 

Pimplikar S. on PAPER: Nakaya T. et al., 2006, To Bind or Not to Bind: APP Phosphorylation and Fe65 With the growing realization... 30 Jun 2006. 

Pimplikar S. on LIVE DISCUSSION: Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?, From this debate, it is becoming apparent that the 42:40 ratio hypothesis (increased Ab42/40... 6 Jun 2006. 

Pimplikar S. on NEWS: Paper Alert: Pathology Reversed by Abolishing APP Caspase Site, APP Cytoplasmic Domain: An Orphan No More! A central tenet of the “amyloid cascade... 24 May 2006. 

Pimplikar S. on NEWS: Aiding and Abetting, Hyperactive CDK5 Gives Mouse Tangles, An interesting observation emanating from the studies of Noble et al. is that the... 27 May 2003. 

1 to 30 of 31 results
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ALS Forum

The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
ALS Forum
Polls
 
Should the FDA be allowed to use data from overseas clinical trials?

Absolutely, we are running out of viable subjects in the U.S.
 9
 
Yes, so long as the data is reliable
 31
 
No, the trials are not as rigorous
 3
 
No, the data should be repeated in the U.S.
 5
 
No, the drug sponsors are just trying to cut corners
 3
 
Responses: 51
 
 
 
 
 
Archived Polls
 
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Forum Calendar

Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad